Tag: RXMD

Blue Horseshoe Stocks: WMT Calls & More

Walmart, Inc. WMT

After a period of a couple of trading sessions where WMT has taken considerable abuse on the chart. After appearing to be gearing up to make an impressive run, the stock gapped down considerably on Tuesday and the backslide persisted through yesterday.

This major selloff has brought the stock down to its lowest PPS since November, and had us thinking about a range of calls to slate for observation in the days and weeks ahead. We’re going to signal the WMT 03/16 $90-93 Calls, which should be in line for some solid activity if Walmart mounts the recovery that, at this point, looks very possible.

Hertz Global Holdings, Inc. HTZ

We would like to put HTZ on watch as a possible bounce play this morning. As you can see on the included chart snapshot, the stock is giving off a strong double-bottom signal, and just fell below its 200DMA yesterday.

We’re going to monitor the activity here closely, because as you can see, there is a considerable amount of room to run to the upside, and the stock has been approaching heavily oversold territory.

___________

Avis Budget Group, Inc. CAR

While we’re on the subject of car rental agencies, our eye has also been caught by Avis, whose stock just came down to an area of trendline support, and also posted a Q4 earnings beat.

We’re going to look for opportunities in the CAR 03/16 $42-44 Calls in coming sessions.

Extended Watchlist:
AIMT, SGMO, ETE, PBR, RXMD, STMP, MLNX, MBRX

Blue Horseshoe Stocks: RXMD, CBLI, DNRG Reviews & More

Progressive Care, Inc. RXMD

The only ones not to receive the addition of RXMD in our premarket reports yesterday were our Blue Horseshoe Stocks email subscribers. It was a late-add to our watchlist, and the BHS email had already been published.*

Members of our other lists, our live traders chat members** or readers of the Blue Horseshoe Stocks blog did receive the alert before market open, in time for one of the most epic runs we’ve witnessed in quite awhile.

We witnessed a crossover from subpenny territory at the stock’s morning low of .009, and RXMD was driven deep into Pennyland, as it peaked at a PPS of .049 at around 12:45PM. That represented an astronomical 444% intraday swing. Volume exceeded the 3-month norm by more than 25X.

With that kind of momentum built up, we’ll be certain to continue to track the activity in RXMD as this exciting trading week comes to a close.

*RXMD serves as a reminder to our email subscribers that situations like these do occur, where we catch an opportunity at the last minute, which is why we suggest subscribers of all of our lists also navigate to BlueHorseshoeStocks.com daily, as the most updated version of our reports will always be posted there prior to market open.

**Our live traders chats are conducted on Skype and are open to all of our readers. Send contact request to ‘stocksumo’ for admittance. Below you can see the snapshot of when we handed the idea off to the room:

Cleveland BioLabs, Inc. CBLI

CBLI was one of the main points of focus in yesterday’s premarket report. We caught it in the midst of a premarket Blue-Sky Breakout in the wake of the announcement that the company had entered into a beneficial equity financing arrangement that will yield something on the order of $25M. >>Read PR

We stated that “whenever we run across a stock in this position we’re always on the lookout for dip-and-rip scenarios” and pointed to the 200DMA of 5.35 as the minimum level where we’d need to see support hold on any early pullbacks.

We got exactly what we were looking for as CBLI underwent a slight dip, holding safely above our identified level as it rebounded off of the 5.40-mark, and went on a strong run to a high of 7.24. That was good for intraday gains of up to 34% before it began to pull back. There was also a subsequent swing from 5.75-6.35 for an added 10% move.

Dominovas Energy Corp. DNRG

DNRG was a stock that we tagged earlier this month on the 3rd, and at the time we observed an awesome 150% single-session run from .005-.0125.

Things largely quieted down for the stock until Wednesday of this week, when it began to stir once again. Yesterday it absolutely broke out on an incredible intraday run from .065-.228 (+250%).

Hypothetically, anyone to have picked it up at our observed low of .005, and held to yesterday’s peak could have been looking at gains on the order of a mind-numbing 4,460%

A move like that in a period of just 17 sessions makes DNRG one of the biggest gainers we’ve tracked in recent memory.

Extended Watchlist:
GIGM, LPTN, CUR, DGAZ, MBHC

Blue Horseshoe Stocks: MJMJ, MEET Recaps & More

MeetMe, Inc. MEET

Yesterday we tagged MEET for the first time since last year, and our timing in turning our attention back to it was excellent. On the strength of improved Q2 guidance published in a premarket PR, the stock made a healthy intraday move.

From a morning low of 1.66, MEET went on to hit an even 2.00 high toward the end of the session; a 20% swing. Volume was excessive, on the order of roughly 22x the 3-month average. Ideally, we need to see MEET maintain support at or above the new 200DMA of 1.74 on any pullbacks in order for us to remain interested.

The MaryJane Group, Inc. MJMJ

At the end of last week we were monitoring MJMJ for a bottom, After coming up off its bottom on Tuesday and providing us with a quality  opportunity, MJMJ continued to perform well with a nice intraday surge.

The stock made its way from an early low of .0036, and managed a subsequent high of .0055; a hefty 53% move.

From our observed low of .0027, we’ve seen an overall increase of 104% over a period of just a few sessions. With many cannabis stocks beginning to show increased signs of life lately, we’ll be sure to continue monitoring this play and others in the sector.

Cleveland BioLabs, Inc. CBLI

We want to keep an eye on CBLI after this morning’s big announcement (link below), which has essentially caused the stock to enter into Blue-Sky Breakout mode this morning, cracking through its 200DMA of 5.35 in the premarket. If it can maintain that 200DMA as support on an early pullback, we could see added increases.

Regardless, whenever we run across a stock in this position we’re always on the lookout for dip-and-rip scenarios to occur after a consolidation. It’s a pattern that we’ve seen played out time and time again.

Pazoo, Inc. PZOO

We also noticed a PR published on PZOO for the second consecutive day. After yesterday’s big announcement that the company had fully acquired MA & Associates’ marijuana testing business, today we learned that the company’s other subsidiary has signed a new, potentially lucrative distribution agreement.

Pazoo is another company that falls under the category of those doing everything they can to capitalize on the ever-expanding marijuana sector. It has remained extremely active in pursuing that goal over the entire time we’ve been tracking the stock.

Extended Watchlist:
RXMD, MHR, PTNT, RXII, BWEN, INVT